Multivariate Bayesian analysis for survival using the Weibull proportional hazards model (n = 351)
Variable . | Coefficient . | Standard error . | Hazard ratio (95% CI) . |
---|---|---|---|
Constant | -10.760 | NA | NA |
t(4;14)(p16;q32)* | 0.574 | 0.179 | 1.78 (1.23-2.50) |
t(14;16)(q32;q23)* | 0.513 | 0.286 | 1.67 (0.92-2.83) |
Deletion 17p13* | 0.291 | 0.188 | 1.34 (0.92-1.93) |
▵13* | 0.244 | 0.119 | 1.28 (1.01-1.61) |
t(11;14)(q13;q32)* | -0.213 | 0.163 | 0.81 (0.58-1.11) |
Creatinine, 2 or more vs less than 2 mg/dL† | 0.580 | 0.165 | 1.79 (1.29-2.44) |
PC labeling index, 1% or higher vs less than 1% | 0.441 | 0.123 | 1.55 (1.22-1.97) |
C-reactive protein, 2 or more vs less than 2 mg/dL | 0.435 | 0.175 | 1.54 (1.09-2.16) |
Bone marrow involvement, 30% or higher vs less than 30% | 0.354 | 0.116 | 1.43 (1.14-1.79) |
Variable . | Coefficient . | Standard error . | Hazard ratio (95% CI) . |
---|---|---|---|
Constant | -10.760 | NA | NA |
t(4;14)(p16;q32)* | 0.574 | 0.179 | 1.78 (1.23-2.50) |
t(14;16)(q32;q23)* | 0.513 | 0.286 | 1.67 (0.92-2.83) |
Deletion 17p13* | 0.291 | 0.188 | 1.34 (0.92-1.93) |
▵13* | 0.244 | 0.119 | 1.28 (1.01-1.61) |
t(11;14)(q13;q32)* | -0.213 | 0.163 | 0.81 (0.58-1.11) |
Creatinine, 2 or more vs less than 2 mg/dL† | 0.580 | 0.165 | 1.79 (1.29-2.44) |
PC labeling index, 1% or higher vs less than 1% | 0.441 | 0.123 | 1.55 (1.22-1.97) |
C-reactive protein, 2 or more vs less than 2 mg/dL | 0.435 | 0.175 | 1.54 (1.09-2.16) |
Bone marrow involvement, 30% or higher vs less than 30% | 0.354 | 0.116 | 1.43 (1.14-1.79) |